India to Canada: Dexamethasone Export Trade Route
India has recorded 49 verified shipments of Dexamethasone exported to Canada, representing a combined trade value of $2.3M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $47.4K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 89% of total export value with 15 shipments worth $2.1M USD. On the buying side, TARO PHARMACEUTICALS INC., is the largest importer in Canada with $1.8M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Dexamethasone corridor is one of India's established pharmaceutical export routes, with 49 shipments documented worth a combined $2.3M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 89% of all export value, reflecting the consolidated nature of India's dexamethasone manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $47.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with dexamethasone's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 27.8%, placing it at rank #12 among India's top dexamethasone export destinations globally.
On the import side, key buyers of Indian dexamethasone in Canada include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC , TARO PHARMACEUTICALS INC and 24 others. TARO PHARMACEUTICALS INC., is the single largest importer with 9 shipments valued at $1.8M USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#12
- Annual growth+27.8%
- Demand growth+23.4%
- Regulatory ease81/100
Top 10 Indian Dexamethasone Exporters to Canada
Showing top 10 of 7 Indian suppliers exporting Dexamethasone to Canada, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $138.2K per shipment | 15 | $2.1M | 89.3% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $63.9K per shipment | 3 | $191.6K | 8.3% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $56.2K per shipment | 1 | $56.2K | 2.4% |
| 4 | SUNWAYS INDIA PRIVATE LIMITED Avg $71 per shipment | 2 | $143 | 0.0% |
| 5 | RUCHA ENTERPRISES Avg $11 per shipment | 8 | $91 | 0.0% |
| 6 | 3CUBE MEDICARE PRIVATE LIMITED Avg $2 per shipment | 16 | $32 | 0.0% |
| 7 | 3CUBE MEDICARE PRIVATE LIMITED Avg $0 per shipment | 4 | $0 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting dexamethasone to Canada, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LTD, SUNWAYS INDIA PRIVATE LIMITED, RUCHA ENTERPRISES, 3CUBE MEDICARE PRIVATE LIMITED, 3CUBE MEDICARE PRIVATE LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 15 shipments worth $2.1M USD, giving it a 89% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Dexamethasone Importers in Canada
Showing top 10 of 27 known buyers in Canada receiving Dexamethasone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian dexamethasone in Canada include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC , TARO PHARMACEUTICALS INC, SUN PHARMA CANADA INC, TARO PHARMACEUTICALS INC., among 27 total buyers. The largest importer is TARO PHARMACEUTICALS INC.,, accounting for $1.8M USD across 9 shipments — representing 77% of all dexamethasone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TARO PHARMACEUTICALS INC., | 9 | $1.8M | 76.5% |
| 2 | TARO PHARMACEUTICALS INC | 3 | $191.6K | 8.3% |
| 3 | TARO PHARMACEUTICALS INC | 3 | $164.9K | 7.1% |
| 4 | SUN PHARMA CANADA INC | 1 | $111.3K | 4.8% |
| 5 | TARO PHARMACEUTICALS INC. | 3 | $76.7K | 3.3% |
| 6 | TO THE ORDER | 2 | $143 | 0.0% |
| 7 | TO THE MASTER OF M.V. FEDERAL KIVA | 3 | $34 | 0.0% |
| 8 | TO THE MASTER OF M.V. FEDERAL DART | 1 | $23 | 0.0% |
| 9 | THE MASTER OF SAGA JOURNEY SHIP SPA | 2 | $16 | 0.0% |
| 10 | TO THE MASTER OF M.V. FEDERAL OSHI | 1 | $14 | 0.0% |
Showing top 10 of 27 Dexamethasone importers in Canada on this route.
Top 10 Dexamethasone Formulations Imported by Canada
Showing top 10 of 31 product formulations shipped on the India to Canada Dexamethasone route, ranked by trade value
Canada imports a wide range of dexamethasone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP (FOR CANADA) — accounts for $1.1M USD across 3 shipments. There are 31 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP (FOR CANADA) | 3 | $1.1M | 48.2% |
| 2 | CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP, 7.5ML[45699 PACK X 1 BOTTLE] (BATCH NO. BAF0 | 2 | $505.6K | 21.8% |
| 3 | CIPROFLOXACIN (0.3%) AND DEXAMETHASONE ( | 3 | $191.6K | 8.3% |
| 4 | CIPROFLOXACIN 0 3 AND DEXAMETHASONE 0 1 STERILE OTIC SUSPENSION USP 7 5ML 20598 PACK X 1 BOTTLE | 1 | $111.3K | 4.8% |
| 5 | CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP 7.5ML[37396 PACK X 1 BOTTLE]NOS | 3 | $76.7K | 3.3% |
| 6 | CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% STERILE OTIC SUSPENSION USP FOR CANADA PACK : BOXOF01BTL Batch No. As Pe | 1 | $56.2K | 2.4% |
| 7 | CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% STERILE OTIC SUSPENSION USP FOR CANADA - PACK : BOXOF01BTL Batch No. As | 1 | $55.9K | 2.4% |
| 8 | CIPROFLOXACIN 0.3% AND DEXAMETHASONE | 1 | $52.7K | 2.3% |
| 9 | CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP, 7.5ML[9570 PACK X 1 BOTTLE] | 1 | $51.1K | 2.2% |
| 10 | CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP, 7.5ML[9093 PACK X 1 BOTTLE] | 1 | $48.5K | 2.1% |
Showing top 10 of 31 Dexamethasone formulations imported by Canada on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 20 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's dexamethasone exports to Canada are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 15 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LTD — together account for 100% of total trade value on this route. The average shipment value of $47.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as ciprofloxacin (0.3%) and dexamethasone (0.1%) sterile otic suspension usp, 7.5ml[45699 pack x 1 bottle] (batch no. baf0 and ciprofloxacin (0.3%) and dexamethasone ( , suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TARO PHARMACEUTICALS INC., is the largest importer with 9 shipments worth $1.8M USD — representing 77% of all dexamethasone imports from India on this route. A total of 27 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.3M
- Avg. Shipment
- $47.4K
- Suppliers
- 7
- Buyers
- 27
- Transit (Sea)
- ~25 days
- Annual Growth
- +27.8%
Related Analysis
Reverse Direction
Canada → India — Dexamethasone (Import)Other Dexamethasone Routes
Unlock the Full India to Canada Dexamethasone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 49 shipments on this route.
Frequently Asked Questions — India to Canada Dexamethasone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Dexamethasone to Canada?
The leading Indian exporters of Dexamethasone to Canada are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LTD. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 89% of total trade value on this route.
Q What is the total value of Dexamethasone exports from India to Canada?
India exports Dexamethasone to Canada worth approximately $2.3M USD across 49 recorded shipments. The average value per shipment is $47.4K USD.
Q Which ports does India use to ship Dexamethasone to Canada?
The most active port of origin is SAHAR AIR with 20 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Canada for Dexamethasone?
The average transit time for Dexamethasone shipments from India to Canada is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Canada Dexamethasone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.8% with demand growth tracking at 23.4%. The route is ranked #12 among India's top Dexamethasone export destinations globally.
Q How many suppliers are active on the India to Canada Dexamethasone route?
There are currently 7 active Indian suppliers exporting Dexamethasone to Canada. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 89% of total shipment value.
Q Who are the main importers of Dexamethasone from India in Canada?
The leading importers of Indian Dexamethasone in Canada include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC , TARO PHARMACEUTICALS INC, SUN PHARMA CANADA INC, TARO PHARMACEUTICALS INC.. TARO PHARMACEUTICALS INC., is the largest buyer with 9 shipments worth $1.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Dexamethasone.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 27 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 49 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
49 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists